Univariate survival analyses showed that high rpS6 expression is associated with a poor clinical outcome in patients with RCC (p < 0.001, Figure 6B, cancer-specific survival; for an analysis of progression-free survival see Suppl. This evidence concerns the gene RPS6 and renal cell carcinoma.